Clinical Trial Update: Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating nicotinic treatment for post-chemotherapy subjective cognitive impairment (often called chemo brain) has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemo Brain
• Chemotherapy-related Cognitive Impairment

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Chemo Brain, Chemotherapy-related Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2020-01-21